Pages that link to "Q33685609"

The following pages link to Prevalence of genetic muscle disease in Northern England: in-depth analysis of a muscle clinic population (Q33685609):

Displaying 20 items.

• Facioscapulohumeral dystrophy: the path to consensus on pathophysiology (Q21195884) (← links)
• Prevalence of neurogenetic disorders in the North of England (Q26784050) (← links)
• Congenital muscular dystrophy: from muscle to brain (Q27023097) (← links)
• A TALEN-Exon Skipping Design for a Bethlem Myopathy Model in Zebrafish (Q27301818) (← links)
• Quality improvement in neurology: muscular dystrophy quality measures (Q27348818) (← links)
• Congenital muscular dystrophies: a brief review (Q28255519) (← links)
• Prevalence of congenital muscular dystrophy in Italy: a population study (Q28256516) (← links)
• Guidance in social and ethical issues related to clinical, diagnostic care and novel therapies for hereditary neuromuscular rare diseases: "translating" the translational (Q28485060) (← links)
• A mouse model for dominant collagen VI disorders: heterozygous deletion of Col6a3 Exon 16 (Q28505521) (← links)
• Dysferlin quantification in monocytes for rapid screening for dysferlinopathies (Q30144043) (← links)
• The burden, epidemiology, costs and treatment for Duchenne muscular dystrophy: an evidence review (Q30234649) (← links)
• Diagnostic approach to the congenital muscular dystrophies (Q30767612) (← links)
• Early stages of building a rare disease registry, methods and 2010 data from the Belgian Neuromuscular Disease Registry (BNMDR). (Q30832937) (← links)
• MRI biomarker assessment of neuromuscular disease progression: a prospective observational cohort study. (Q31019878) (← links)
• Mutational spectrum of Chinese LGMD patients by targeted next-generation sequencing. (Q33558590) (← links)
• Limb-girdle muscular dystrophies: where next after six decades from the first proposal (Review). (Q33608787) (← links)
• The UK Myotonic Dystrophy Patient Registry: facilitating and accelerating clinical research (Q33627845) (← links)
• A founder mutation in Anoctamin 5 is a major cause of limb-girdle muscular dystrophy (Q33685709) (← links)
• Human adipose-derived stem cell transplantation as a potential therapy for collagen VI-related congenital muscular dystrophy (Q33745931) (← links)
• Allele-specific Gene Silencing of Mutant mRNA Restores Cellular Function in Ullrich Congenital Muscular Dystrophy Fibroblasts (Q33834776) (← links)